Li Tu

511 total citations
14 papers, 411 citations indexed

About

Li Tu is a scholar working on Cancer Research, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Li Tu has authored 14 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cancer Research, 6 papers in Molecular Biology and 4 papers in Biomedical Engineering. Recurrent topics in Li Tu's work include MicroRNA in disease regulation (4 papers), Nanoplatforms for cancer theranostics (4 papers) and Advanced Nanomaterials in Catalysis (4 papers). Li Tu is often cited by papers focused on MicroRNA in disease regulation (4 papers), Nanoplatforms for cancer theranostics (4 papers) and Advanced Nanomaterials in Catalysis (4 papers). Li Tu collaborates with scholars based in China and United States. Li Tu's co-authors include Lijun Cai, Jinyong Tian, Guanghong Xie, Wei Du, Xiao-Mo Huang, Xiang Qu, Qian Zhang, Ran Gu, Huan Yao and Shuaidong Huo and has published in prestigious journals such as ACS Applied Materials & Interfaces, Journal of Colloid and Interface Science and Nanoscale.

In The Last Decade

Li Tu

13 papers receiving 405 citations

Peers

Li Tu

BIOMA

Huijuan Zhou China

Xiaoning Lin China

Yanyue Wu China

Jinmu Deng China

Rekha Srinivasan United States

Biling Chen China

Yuling Mao China

Rongjun Qian China

Huijuan Zhou China

Li Tu

237 ×0.9

76 ×0.4

73 ×0.8

41 ×0.7

BIOMA

42 ×0.7

Citations per year, relative to Li Tu Li Tu (= 1×) peers Huijuan Zhou

Countries citing papers authored by Li Tu

Since Specialization

Citations

This map shows the geographic impact of Li Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Tu more than expected).

Fields of papers citing papers by Li Tu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Tu. The network helps show where Li Tu may publish in the future.

Co-authorship network of co-authors of Li Tu

This figure shows the co-authorship network connecting the top 25 collaborators of Li Tu. A scholar is included among the top collaborators of Li Tu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Tu. Li Tu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Tu, Li, Song Ouyang, Zengli Wang, et al.. (2025). PD-L1/ITGB4 Axis Modulates Sensitivity of Hepatocellular Carcinoma to Sorafenib via FAK/AKT/mTOR Signaling Pathway. ImmunoTargets and Therapy. Volume 14. 815–830. 1 indexed citations

Yu, Yingyan, et al.. (2025). [The TGF‑β/miR-23a-3p/IRF1 axis mediates immune escape of hepatocellular carcinoma by inhibiting major histocompatibility complex class I].. PubMed. 45(7). 1397–1408.

Wang, Li, Li Tu, Yong Zhang, et al.. (2024). Folic Acid-Modified Milk Exosomes Delivering c-Kit siRNA Overcome EGFR-TKIs Resistance in Lung Cancer by Suppressing mTOR Signaling and Stemness. International Journal of Biological Sciences. 21(1). 382–399. 3 indexed citations

Ke, Sunkui, Li Tu, Shengqiang Chen, et al.. (2023). Glutathione/pH-responsive copper-based nanoplatform for amplified chemodynamic therapy through synergistic cycling regeneration of reactive oxygen species and dual glutathione depletion. Journal of Colloid and Interface Science. 652(Pt A). 329–340. 12 indexed citations

Wu, Liang, Quanyi Jin, Jiawei Liu, et al.. (2022). Myeloperoxidase-targeted nanotheranostics for self-enhanced synergetic photo/chemo/chemodynamic therapy. Materials Today Chemistry. 23. 100740–100740. 8 indexed citations

Liu, Chunyang, Li Tu, Peiyan Yang, et al.. (2022). GSH-Responsive and Hypoxia-Activated Multifunctional Nanoparticles for Synergetically Enhanced Tumor Therapy. ACS Biomaterials Science & Engineering. 8(5). 1942–1955. 24 indexed citations

Liao, Zhihuan, Li Tu, Xuejian Li, Xing‐Jie Liang, & Shuaidong Huo. (2021). Virus-inspired nanosystems for drug delivery. Nanoscale. 13(45). 18912–18924. 30 indexed citations

Fan, Zhongxiong, Sijin Xiang, Li Tu, et al.. (2020). Tumor-Specific Endogenous Fe^II-Activated, MRI-Guided Self-Targeting Gadolinium-Coordinated Theranostic Nanoplatforms for Amplification of ROS and Enhanced Chemodynamic Chemotherapy. ACS Applied Materials & Interfaces. 12(13). 14884–14904. 47 indexed citations

Cai, Lijun, Li Tu, Xiao-Mo Huang, et al.. (2020). LncRNA MALAT1 facilitates inflammasome activation via epigenetic suppression of Nrf2 in Parkinson’s disease. Molecular Brain. 13(1). 130–130. 116 indexed citations

10.

Cai, Lijun, Li Tu, Li Tian, et al.. (2020). Up-regulation of microRNA-375 ameliorates the damage of dopaminergic neurons, reduces oxidative stress and inflammation in Parkinson’s disease by inhibiting SP1. Aging. 12(1). 672–689. 47 indexed citations

11.

Tu, Li, et al.. (2019). <p>MiR-34c acts as a tumor suppressor in non-small cell lung cancer by inducing endoplasmic reticulum stress through targeting HMGB1</p>. OncoTargets and Therapy. Volume 12. 5729–5739. 22 indexed citations

12.

Cai, Lijun, Li Tu, Tian Li, et al.. (2019). Downregulation of lncRNA UCA1 ameliorates the damage of dopaminergic neurons, reduces oxidative stress and inflammation in Parkinson's disease through the inhibition of the PI3K/Akt signaling pathway. International Immunopharmacology. 75. 105734–105734. 78 indexed citations

13.

Ke, Sunkui, Lihuang Li, Li Tu, et al.. (2018). Molybdenum Disulfide Quantum Dots Attenuates Endothelial-to-Mesenchymal Transition by Activating TFEB-Mediated Lysosomal Biogenesis. ACS Biomaterials Science & Engineering. 5(2). 1057–1070. 18 indexed citations

14.

Tu, Li, Li Wang, Jianlin Long, et al.. (2016). The accumulation of macrophages attenuates the effect of recombinant human endostatin on lung cancer. OncoTargets and Therapy. Volume 9. 6581–6595. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Huijuan Zhou Breakdown of academic impact, for papers by Xiaoning Lin Breakdown of academic impact, for papers by Yanyue Wu Breakdown of academic impact, for papers by Jinmu Deng Breakdown of academic impact, for papers by Rekha Srinivasan Breakdown of academic impact, for papers by Biling Chen Breakdown of academic impact, for papers by Yuling Mao Breakdown of academic impact, for papers by Rongjun Qian